Purpose: To report the initial clinical experience with the radixact synchrony lung with respiratory (LWR) technique in stereotactic body radiotherapy (SBRT) for lung tumors, focusing on feasibility, dosimetric performance, and early clinical outcomes using both standard and extended fractionation regimens. Methods: Twenty patients with primary or metastatic lung tumors were treated using the Synchrony LWR technique. Patients were selected based on respiratory stability and favorable imaging characteristics. All patients underwent a Synchrony simulation, which included tumor tracking volume (TTV) definition and kV radiograph acquisition to assess their suitability for treatment with this technique. Treatment plans were generated using Precision TPS with VoloUltra. Plan verification, including gamma analysis and point dose measurements, was performed using the PTW Octavius system and dynamic motion QA. Synchrony model parameters, treatment times, and intrafraction interruptions were analyzed. Clinical follow‐up included imaging and toxicity assessment. Results: Treatment was successfully delivered in all patients with median beam‐on and treatment durations of 9.1 and 14.5 min, respectively. The median number of intrafraction interruptions was 1.95, and none of the fractions were canceled due to prolonged delivery. The mean kV imaging dose per fraction was 0.90 cGy. Dosimetric QA under motion showed gamma passing rates >93% and < 2% deviation in point dose. At a median follow‐up of 9 months, the local control rate was 100%, with no grade ≥2 toxicities observed. Conclusions: The Radixact Synchrony LWR technique enables efficient and non‐invasive respiratory motion management in lung SBRT. This early experience demonstrates its feasibility with clinically acceptable delivery accuracy and promising short‐term clinical outcomes.
31 May 2020 in Süleyman Demirel Üniversitesi Fen Edebiyat Fakültesi Fen Dergisi
In this study, we compared the dose-volume parameters for treatment of thoracic esophageal cancer with treatment plans for 3D-CRT, IMRT, IMAT and HT. 15 thoracic esophagus patients who were treated in our clinic between 2017-2018 years were selected. PTV volumes were between 205 and 445.4 cc with an average of 355.2 cc. 3D-CRT, IMRT, IMAT and HT radiotherapy plans were created for each patient using the same contours and the same dose planning prescription. Total dose of 50.4 Gy for all patients was planed with 180 cGy dose per a fraction in total 28 fractions. For PTV; when the four treatment techniques were compared, HI values were 3D-CRT 0.84 ± 0.0, IMRT 0.57 ± 0.05, IMAT 0.06 ± 0.013, HT 0.08 ± 0.03 (p <0.05). CI values were found for 3D-CRT as 1.84 ± 0.2, for IMRT as 1.25 ± 0.05, for IMAT as 1.19 ± 0.04, for HT as 1.2 ± 0.06 (p <0.05). IMRT and IMAT techniques provided better OAR protection compared to other techniques in all lung and heart comparisons. The lowest doses for Dmax and D1% of Spinal Cord were provided by HT technique. We found that IMRT, IMAT and HT techniques have lower critical organ doses than 3D-CRT technique for treating torasic esophageal cancer. Considering the current evidence of the relationship between radiation-induced cardiac toxicity in the literature and the dose-volume parameters after treatment for esophageal cancer in our study, we can say that dose plans are better for IMRT and IMAT plans than 3D-CRT and HT in terms of lung and heart doses.
27 September 2023 in Acibadem Universitesi Saglik Bilimleri Dergisi
Background/Purpose: To investigate the perception of working radiation therapists (RTTs) regarding the contribution of RTT training provided in Turkey to their clinical practice. Methods: The study employed a questionnaire consisting of 22 questions. The questionnaire was distributed via email to RTTs working in Turkey. The questionnaire explored various aspects of the participants' education, including their internship opportunities, the duration of their internships, the devices they worked with, and the adequacy of their experiences. Results: 181 RTTs participated in the survey. The majority of participants (57.3%) completed their education at foundation universities, while 42.7% attended state universities. During their education, 80.5% of participants found the internship opportunities offered by their schools to be adequate. 92.6% of the participants reported that the experience they gained during their internship had a positive impact on their working life. A statistically significant relationship was observed between the adequacy of the device variety used during the internship and the contribution of the internship to their working life (p<0.05). Conclusion: The majority of RTT who participated in the survey found that the education they completed were largely sufficient in terms of contributing to their working lives.
26 June 2026 in Irish Journal of Medical Science (1971 -)
We aimed to compare two radiotherapy techniques (the robotic-based linear accelerator Stereotactic Body Radiotherapy (SBRT) and linear accelerator-based Intensity Modulated Arc Therapy (IMAT)) dosimetrically on Early Glottic Larynx Cancerx (EGL) treatment plans in the terms of target volume and critical organ doses. The computerized tomography (CT) images of 15 patients treated with EGL diagnosis were used retrospectively. The Planning Target Volumes (PTV) was generated with a margin of 0.5 cm from the laryngeal volume. The PTV dose was defined as 45 Gy delivered in 10 fractions within each of treatment plans. At least 95% of PTV treatment volumes (D95%) were to receive the treatment dose. The average PTV volume was 95.56 cm3 (range: 68.8 cm3 - 142.6 cm3). The average D98%, D2% and Dmean values of PTV were lower in IMAT plan than in CK plan. In CK plans, the mean of the spinal cord maximum dose (Dmax) for all patients was statistically significantly lower than in IMAT plans. Dmax and Dmean values for the right and left carotid arteries was significantly lower in IMAT plans. Also, the Dmean value of thyroid gland was significantly lower in IMAT plans. Our dosimetric comparison study made using images of 15 EGL cancer patients shows that the desired critria for the critical organ doses can not reached with CK plans, especially when the treatment volume is large.
6 October 2026 in Radiation and Environmental Biophysics